Search

Search Constraints

You searched for: Author/Creator Guillerm, Erell

Search Results

1. AXIN2 germline testing in a French cohort validates pathogenic variants as a rare cause of predisposition to colorectal polyposis and cancer. Issue 4 (21st December 2022)

2. Complete resection of ulcerating, infiltrative, voluminous differentiated thyroid carcinoma. Issue 2 (28th February 2022)

3. Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial. (29th December 2020)

4. Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma. Issue 3 (2nd August 2022)

5. DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS. (11th November 2019)

6. Droplet digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery. Issue 8 (7th June 2016)

7. Evaluation of two new highly multiplexed PCR assays as an alternative to next‐generation sequencing for IDH1/2 mutation detection. Issue 22 (17th October 2022)

8. HSP110 T17 simplifies and improves the microsatellite instability testing in patients with colorectal cancer. Issue 6 (1st February 2016)

9. IDH-wildtype lower-grade diffuse gliomas: the importance of histological grade and molecular assessment for prognostic stratification. Issue 6 (11th November 2020)

10. PATH-16. MOLECULAR PATHOLOGY AND CLINICAL CHARACTERISTICS OF MMR DEFICIENCY (MMRd) IN DIFFUSE GLIOMAS. (5th November 2018)